Danske Bank A/S
10.2.2021 09:08:23 CET | Globenewswire | Press release
10 February 2021
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Akelius Residential Property Financing B.V.
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 9 February 2021, Danske Bank A/S (contact: Syndicate – Morten Grove; telephone: + 45 45 14 70 33) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
Securities
| Issuer: | Akelius Residential Property Financing B.V. |
| Guarantor(s) (if any): | Akelius Residential Property AB (publ) |
| Aggregate nominal amount: | EUR 600,000,000 |
| Description: | EUR 600,000,000 0.750 per cent. Unsecured Fixed Rate Notes due 22 February 2030, ISIN: XS2301127119 |
| Offer price: | 98.983 per cet. |
Stabilisation Manager(s)
| Name(s): | BNP Paribas, Danske Bank and Swedbank |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Bavarian Nordic A/S27.10.2026 16:52:07 CET | Press release
Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile
Bavarian Nordic A/S27.10.2026 16:52:07 CET | Pressemeddelelse
Bavarian Nordic leverer og donerer vacciner til globalt nødberedskabslager for mpox-vacciner
TrueCommerce27.10.2026 16:43:16 CET | Pressemeddelelse
TrueCommerce styrker sin ledelse med en ny CFO og Managing Director for EMEA, samtidig med at virksomheden sætter fart på sin AI-drevne strategi for forsyningskædenetværket
Fluke Corporation27.10.2026 16:30:00 CET | Press release
Fluke Takes Decades of Engineering Excellence to New Heights in Near-Space Challenge
AdipoPharma27.10.2026 15:22:24 CET | Press release
AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
